Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

Patent 11767320 was granted and assigned to Incyte on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 27 Sep, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 27 Sep, 2023
Edits made to:
Infobox (+46 properties)
Article (+304 characters)
‌

 US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

Article

Patent abstract

Disclosed are compounds of Formula I, methods of using the compounds for inhibiting KRAS activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with KRAS activity such as cancer.

Infobox
Is a
Patent
Patent
Patent Applicant
Incyte
Incyte
Current Assignee
Incyte
Incyte
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11767320
Patent Inventor Names
Taisheng Huang
Wenqing Yao
Xiaozhao Wang
Date of Patent
September 26, 2023
Patent Application Number
17449696
Date Filed
October 1, 2021
Patent Citations
‌
US Patent 7592453 Fused quinoline derivative and use thereof
‌
US Patent 7897609 Aryl substituted imidazonaphthyridines
‌
US Patent 7943770 Fused quinoline derivative and use thereof
‌
US Patent 7973163 Fused quinoline derivative and use thereof
‌
US Patent 8034802 Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
‌
US Patent 8110602 Compounds comprising heterocyclic-substituted piperidine for treating pain
‌
US Patent 8143270 2-amino 1
‌
US Patent 8158794 Hydroxyalkyl substituted imidazoquinoline compounds and methods
‌
US Patent 8207187 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
‌
US Patent 8513250 Imidazolo-heteroaryl derivatives with antibacterial properties
‌
US Patent 8557984 Imidazo [4, 5-C] quinoline derivatives as bromodomain inhibitors
‌
US Patent 8563565 Pyrazoloquinoline derivatives
‌
US Patent 8637670 Imidazo [4,5-C]quinoline derivatives and their use in the treatment of tumors and/or inflammation
‌
US Patent 8658666 Substituted imidazoquinolines and imidazonaphthyridines
‌
US Patent 8846710 Method of preferentially inducing the biosynthesis of interferon
‌
US Patent 8895581 1
‌
US Patent 9062046 Substituted imidazoquinoline derivatives as kinase inhibitors
‌
US Patent 9169246 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
‌
US Patent 9550776 Pyridinylpyrazoloquinoline compounds
‌
US Patent 9573947 Salt of pyrazoloquinoline derivative, and crystal thereof
‌
US Patent 9694006 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
‌
US Patent 9771327 Compounds and methods for the treatment of cystic fibrosis
‌
US Patent 9873683 P2X4 receptor antagonist
‌
US Patent 9873694 Imidazole quinoline-based immune system modulators
‌
US Patent 10039753 Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors
‌
US Patent 10493071 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
‌
US Patent 10544138 Tricyclic kinase inhibitors of MELK and methods of use
‌
US Patent 11046699 Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses
‌
US Patent 11053240 2-amino-quinoline derivatives
Patent Primary Examiner
‌
John M Mauro
CPC Code
‌
C07B 2200/05
‌
C07D 471/04
‌
A61P 37/00
‌
A61P 35/00
‌
A61P 29/00

Find more entities like US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.